Rheumatology NewsHigh Prevalence of Anxiety, Depression, Fibromyalgia With RA and OA Signals Need for ScreeningAugust 2, 2024OsteoarthritisRheumatoid Arthritis
Rheumatology NewsSteroids’ 75th Anniversary: Clinicians Strive to Use LessJuly 25, 2024Rheumatoid ArthritisPsoriatic ArthritisPediatricsLupus & Connective Tissue Diseases
Rheumatology NewsNew Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on SteroidsJuly 25, 2024Lupus & Connective Tissue DiseasesRheumatoid ArthritisVasculitis
Rheumatology NewsFinancial Hardship Common With Rheumatologic Disease: How Can Doctors Help?July 23, 2024Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
Rheumatology NewsRecurrent Monoarthritis: Does Microwave Ablation Help?July 23, 2024Rheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsEarly RA Diagnosis and Treatment Lowers Treatment CostsJuly 23, 2024Rheumatoid Arthritis
Rheumatology NewsMaking Repeated Treatment Changes May Help Resolve Difficult-to-Treat RAJuly 9, 2024Rheumatoid Arthritis
Rheumatology NewsBaricitinib Outperforms TNF Inhibitors in Real-World RA TrialJune 28, 2024Rheumatoid Arthritis
Rheumatology NewsSelective JAK 1 Inhibitor for RA Proves Promising in Phase 3 TrialJune 20, 2024Rheumatoid Arthritis
Rheumatology NewsLong-Term OA, RA Symptom Improvement Seen with Plant-Based Diet, Lifestyle ChangesJune 18, 2024OsteoarthritisRheumatoid Arthritis
Rheumatology NewsTiming Pneumococcal Vaccination in Patients with RA Starting Methotrexate: When’s Best?June 18, 2024Rheumatoid Arthritis
Rheumatology NewsLow Infection Risk, Apart from Herpes Zoster, Seen in Real-World JAK Inhibitor Data for RAJune 14, 2024Rheumatoid Arthritis
Rheumatology NewsHaving More Tender Than Swollen Joints Worsens Outcomes in Early Rheumatoid ArthritisJune 12, 2024Rheumatoid Arthritis
Rheumatology NewsEULAR 2024 Preview: Therapeutics in Development Take Center StageJune 11, 2024Rheumatoid ArthritisPsoriatic ArthritisPediatricsOsteoarthritisLupus & Connective Tissue Diseases
Rheumatology NewsClear Coverage Preference for Humira Over Biosimilars Seen in Most Medicare Part D PlansJune 7, 2024Business of MedicineRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
